Stengone Carmine N. bought CTNM
July 8, 2026 · Form 4 insider transaction
Stengone Carmine N. bought 2,500 shares of Contineum Therapeutics, Inc. at $1.01 per share, a transaction worth $2.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,500
Price
$1.01
Total value
$2.5K
InsiderStengone Carmine N.
Role—
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateJuly 8, 2026
Filing dateJuly 8, 2026
Shares owned after19,717
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.